NRT Smoking Cessation Aids in New Zealand

NRT Smoking Cessation Aids in New Zealand

  • November 2017 •
  • 19 pages •
  • Report ID: 150150
The main driver of growth in NRT smoking cessation aids is the campaign for a Smokefree New Zealand by the year 2025, which aims to achieve under 5% smoking prevalence by 2025. This initiative led to continued government-enforced excise tax rises, legislated until the year 2020. In addition, those who want to quit smoking are encouraged to move to NRT smoking cessation aids, which are government-funded through Quitline. A registered participant can get a four-week supply of patches, lozenges or...

Euromonitor International’s NRT Smoking Cessation Aids in New Zealand report offers a comprehensive guide to the size and shape of the market at a national level. It provides the latest retail sales data 2012-2016, allowing you to identify the sectors driving growth. Forecasts to 2021 illustrate how the market is set to change.

Product coverage:
NRT Gum, NRT Inhalators, NRT Lozenges, NRT Patches, Other NRT.

Data coverage:
market sizes (historic and forecasts), company shares, brand shares and distribution data.

Why buy this report?
* Get a detailed picture of the NRT Smoking Cessation Aids market;
* Pinpoint growth sectors and identify factors driving change;
* Understand the competitive environment, the market’s major players and leading brands;
* Use five-year forecasts to assess how the market is predicted to develop.

We are very sorry, but an error occurred.
Please contact if the problem remains.

Country=NewZealand Industry=OTC ParentIndustry=LifeSciences Date=201711 Topic=Demand Publisher=EuromonitorInternational Price=1000